Elucidata is a pioneering life sciences MLOps company for the future that transforms biological discovery by integrating different forms of biomedical data. They support discovery programs at Pfizer, Bristol Myers Squibb, Genentech, Stanford and Yale and have 35+ research partners from premier biopharma companies and research labs. They are a 150+ multi-disciplinary team of experts based across the US, Canada, and India. In September 2022, they raised $16 million in their Series A round led by Eight Roads and F-Prime along with their old investors Hyperplane and IvyCap.